Needle Gauge Is Not a Spec: How Clinics Should Buy Needles, Syringes, and Cannulas

When an injector asks purchasing to "just order some 27G cannulas and 30G needles like last year," the clinic is writing a purchase order to a single dimension instead of a medical device specification. Gauge defines nominal outer diameter—nothing else. It does not establish inner lumen diameter, wall thickness, bevel geometry, cannula tip configuration, lateral port placement, ISO hub connection standard, single-use sterile packaging validation, or regulatory clearance under the United States Food and Drug Administration (FDA) device classification system.

Substituting a cheaper same-gauge cannula for the SKU named in a filler's Directions for Use (DFU) is not a like-for-like purchase. Labeled sterility, homogeneity, and performance apply to the hardware that was evaluated with that product, not to every device that shares a gauge number. Treating peripheral intravenous (IV) catheters and hypodermic needles as interchangeable hospital commodities is a second, classification-level error on the procedural tray.

This guide details how aesthetic medical directors, practice managers, and procurement coordinators should specify and buy sterile hypodermic needles, empty piston syringes, and aesthetic microcannulas under US regulatory frameworks and international manufacturing standards.

---

Is "27G Cannula" or "30G Needle" a Complete Purchase Specification?

A gauge number is an incomplete specification. The Birmingham Wire Gauge (or Stubs Iron Wire Gauge) system historically standardized wire thicknesses, where higher numbers designate smaller outer diameters. Under modern medical device standards—specifically ISO 7864:2016 (Sterile hypodermic needles for single use) and ISO 9626:2016 (Stainless steel needle tubing for the manufacture of medical devices)—a complete procurement line must define at least eight independent parameters:

1. Regulatory Classification & Product Code: 21 CFR classification and FDA 3-letter product code (e.g., FMI vs. QNS).
2. Nominal Outer Diameter (Metric & Gauge): Labeled metric outer diameter (mm) alongside Birmingham gauge.
3. Tubing Wall Category: Regular Wall (RW), Thin Wall (TW), Extra Thin Wall (ETW), or Ultra Thin Wall (UTW), which dictates inner lumen diameter and extrusion resistance for viscous hyaluronic acid gels.
4. Usable Length: Nominal millimeter and imperial length (e.g., 13 mm / ½ inch vs. 38 mm / 1½ inch).
5. Tip & Bevel Geometry: The labeled bevel (regular/long or short) for a hypodermic needle, or a closed blunt tip with a labeled side-port for a microcannula. Do not infer a procedure from bevel angle.
6. Hub Connector Standard: ISO 80369-7 Luer lock or slip connector (rigid or semi-rigid polymer), color-coded to ISO 6009:2016.
7. Sterility & Packaging: Validated sterile barrier (Ethylene Oxide gas or Gamma radiation), labeled sterile single-use, non-pyrogenic, with lot number and expiration date.
8. Substantial Equivalence / 510(k) or PMA Reference: Verifiable FDA 510(k) clearance number or Premarket Approval (PMA) accessory listing matching the manufacturer's trade name and labeled indications.

┌────────────────────────────────────────────────────────────────────────┐
│               INCOMPLETE VS. SPECIFICATION-LED PURCHASE LINE           │
├────────────────────────────────────────────────────────────────────────┤
│  INCOMPLETE (High Risk):                                               │
│  "27G x 1.5 in microcannulas - 2 boxes"                                │
│                                                                        │
│  SPECIFICATION-LED (Auditable & Defensible):                          │
│  - Device: Sterile single-use blunt aesthetic microcannula             │
│  - Regulation: 21 CFR 880.5570, Class II, product code FMI            │
│  - Identity: Trade name + 510(k) for that SKU, or the PMA-named       │
│    accessory if the filler DFU names one (these are not substitutes)  │
│  - Tubing: labeled gauge + metric OD + length + wall type (RW/TW/ETW) │
│  - Connector: ISO 80369-7 Luer lock female hub, ISO 6009 hub color    │
│  - Tip / port: closed blunt tip with labeled side-port                │
│  - Sterilization: labeled sterile single-use (EO or gamma), UDI / lot │
│  - Channel: authorized manufacturer or the DFU-named purchase channel │
└────────────────────────────────────────────────────────────────────────┘

When specifying hypodermic hardware, clinic purchasing staff can consult specialized technical references, such as the buyer guide to hypodermic needle gauge, length, and wall type specifications, to treat metric outer diameter, length, wall type, and ISO 6009 hub color as separate purchase-order fields. That hypodermic table is not an IV-cannula color chart and not a procedure-by-gauge protocol.

For wider clinic operations, inventory unit costs and procedure margin stacks belong in our analysis of med spa consumable unit economics and sourcing, whereas this guide focuses strictly on line-item device specification, regulatory classification, and Directions for Use compliance.

---

How Do FMI Hypodermic Needles Differ From FOZ IV Cannulas and PMA Microcannulas?

A frequent procurement error in multidisciplinary aesthetic clinics and medical spas is treating all "cannulas" and "needles" as generic hospital supplies. Under FDA regulations, hypodermic injection hardware, intravascular infusion catheters, and dermal filler delivery accessories occupy distinct regulatory classifications under Title 21 of the Code of Federal Regulations (21 CFR):

1. Hypodermic Single-Lumen Needles (21 CFR 880.5570, Product Code FMI)

Under 21 CFR 880.5570, a hypodermic single-lumen needle is a Class II device defined as a metal tube sharpened at one end and designed with a female connector at the other end to mate with a male connector of a piston syringe or intravascular administration set. FDA's openFDA 510(k) index (last updated 17 August 2026) listed 692 records under product code FMI.

Certain aesthetic microcannulas are cleared under product code FMI as hypodermic needles with blunt tips. For example, 510(k) K223327 (cleared February 16, 2023 for Shanghai Kindly) covers "Sterile Aesthetic Cannula and Hypodermic Needle" under FMI, indicated for intradermal fluid injection in adults greater than 21 years old. Another example is K200017 (Eclipse DermaFlex, cleared November 5, 2020). A 510(k) in this category is not evidence that the SKU is the cannula named in a filler PMA DFU.

2. Intravascular Catheters / IV Cannulas (21 CFR 880.5200, Product Code FOZ)

Peripheral IV catheters—frequently called "IV cannulas" in hospital purchasing—fall under 21 CFR 880.5200 (Catheter, Intravascular, Therapeutic, Short-Term Less Than 30 Days), product code FOZ. These devices consist of a flexible polymer sheath (e.g., PTFE, FEP, or polyurethane) over an internal metal introducer needle, designed for venous access and fluid administration.

Procurement Rule: Never copy hospital GPO IV catheter charts or standard hospital IV color codes onto dermal filler or toxin procurement sheets. While ISO 6009:2016 establishes international color coding for hypodermic needle hubs (e.g., 30G is yellow, 27G is medium grey, 25G is orange, 22G is black), IV catheter color coding follows separate conventions under ISO 10555-5 (where 22G is blue, 20G is pink, 18G is green). Ordering "22G cannulas" from a general hospital vendor without specifying 21 CFR 880.5570 / FMI can result in receiving flexible polymer peripheral venous lines rather than rigid stainless-steel aesthetic microcannulas.

3. PMA-Named Dermal Filler Cannula Hardware

Certain dermal fillers have specific microcannula models evaluated and approved directly within their Premarket Approval (PMA) applications. In these cases, the cannula is not merely an open-ended generic tool; it is an approved accessory specified in the device's labeling and Directions for Use.

---

What Needle Does the Botox Cosmetic Label Name, and What Hardware Does the Voluma DFU Name?

Purchasing decisions must align with the primary source labeling of the drugs and devices administered in the practice.

Botox Cosmetic (onabotulinumtoxinA) Labeling Requirements

According to the FDA-approved prescribing information for BOTOX Cosmetic (DailyMed SPL, effective October 18, 2024), preparation and administration instructions specify:

Draw properly reconstituted toxin into the sterile syringe, preferably a tuberculin syringe, and expel any air bubbles in the syringe barrel. Remove the needle used to reconstitute the product and attach a 30-33 gauge needle. Confirm the patency of the needle.

The labeling establishes three clear procurement boundaries:

1. Reconstitution uses a separate sterile needle and syringe. The SPL does not name a reconstitution-needle gauge; that is a distinct purchase line from the 30–33 gauge injection needle.
2. After reconstitution, the injection hardware must be a 30-gauge to 33-gauge sterile needle.
3. The drug is supplied as a single-dose vial. Syringes and needles cannot be reused across patients. Detailed lot tracking for drug vials is covered in our Botox vial log and reconstitution workflow.

┌────────────────────────────────────────────────────────────────────────┐
│                   BOTOX COSMETIC VS. VOLUMA XC HARDWARE                │
├────────────────────────────────────────────────────────────────────────┤
│  BOTOX COSMETIC (onabotulinumtoxinA) - DailyMed SPL Oct 2024           │
│  ├─ Syringe: Sterile syringe, preferably tuberculin                    │
│  ├─ Reconstitution: Separate sterile needle (gauge not named on SPL)   │
│  └─ Injection: 30–33 gauge sterile hypodermic needle                   │
│                                                                        │
│  JUVÉDERM VOLUMA XC (cross-linked HA) - PMA P110033/S070 DFU          │
│  ├─ Pre-filled syringe: volume as stated on the syringe and carton     │
│  ├─ Needle options: 27G ½" needle or 25G 1" needle                     │
│  └─ Cannula option: TSK STERiGLIDE 25G 1½" microcannula                │
│     *Not in carton; purchase through AbbVie. Cannula S&E evaluated     │
│      only with this SKU. Temple indication is needle, not cannula.     │
└────────────────────────────────────────────────────────────────────────┘

Juvéderm Voluma XC Directions for Use (PMA P110033)

The labeled hardware for dermal fillers is governed by Premarket Approval regulations. For Juvéderm Voluma XC, the FDA approved PMA supplement P110033/S042 on August 29, 2019, specifically updating the labeling to include the use of a microcannula. Supplement S070 (approved October 6, 2023) is a panel-track labeling change for supraperiosteal injection to augment the temple in adults over 21 — it is not a second cannula approval.

According to the official Voluma XC Directions for Use (DFU PDF P110033S070C), the authorized delivery hardware is explicitly defined:

• Needle options: 27G ½-inch needle or 25G 1-inch needle.
• Cannula option: 25G 1½-inch cannula.
• Specified SKU: The TSK STERiGLIDE 25G 1½-inch cannula is not supplied in the carton but is available for purchase through AbbVie. The DFU also states that the safety and effectiveness of cannula injection of VOLUMA XC has only been clinically evaluated with that TSK STERiGLIDE 25G 1½-inch cannula.
• Temple vs cheek: Cheek and chin instructions allow the 27G ½-inch or 25G 1-inch needle or a 25G 1½-inch cannula. Temple volumizing is described with the 27G ½-inch or 25G 1-inch needle. A separate precaution states that the safety of VOLUMA XC with cannula to improve temple hollowing has not been established.
• Mandatory handling caveat: "JUVÉDERM VOLUMA XC is to be used as supplied. Modification or use of the product outside the Directions for Use may adversely impact the sterility, homogeneity, and performance of the product."
• Skin of color caution: "The safety of JUVÉDERM VOLUMA XC with cannula for cheek augmentation has not been established in patients with Fitzpatrick Skin Types V and VI." That is a labeled limit on the named cannula pathway, not a general claim that cannulas are unsafe in darker skin.

Procurement consequence: If a clinic injects Voluma XC with a cannula on-label, purchasing should procure the designated TSK STERiGLIDE 25G 1½-inch cannula through the authorized AbbVie channel. Substituting a third-party same-gauge cannula is a departure from the hardware named in the DFU. Licensed providers retain off-label clinical discretion under state practice acts; medical directors should treat unlabeled substitution as a labeling and quality decision, not as a silent equivalent SKU.

For practices auditing supply chains and verifying distributor authenticity against gray-market diversion, refer to our protocol on counterfeit Botox and dermal filler supply chain verification.

---

When Is a Low-Dead-Space Needle a Different Product Code (QNS)?

Low-dead-space (LDS) needles and syringes have gained widespread adoption in aesthetic medicine to minimize residual product left in the hub after injection. In botulinum toxin and skin-booster workflows, residual hub volume represents costly wasted drug.

However, purchasing teams must recognize that FDA treats low-dead-space needles as a distinct regulatory category:

Product Code QNS vs. Product Code FMI

Under 21 CFR 880.5570, standard single-lumen hypodermic needles are classified under product code FMI. Needles specifically engineered, tested, and labeled to reduce dead volume are classified under product code QNS (Low Dead Space Needle, Single Lumen, Hypodermic).

A primary example is FDA 510(k) K231734 (cleared March 8, 2024 for TSK Laboratory International Japan KK, predicate K210444):

• Device Names: STERiJECT Low Dead Space and STERiJECT The Invisible Needle.
• Product Code: QNS (Class II).
• Residual Dead Volume: Labeled dead volume of 0.0028 mL. The 510(k) summary does not publish a conventional-FMI hub residual as a comparator.
• ISO Standard Exception: The K231734 clearance summary notes that the device meets ISO 80369-7 with the exception of needle hub length, which is the geometry that creates the dead-space cavity, and that there is no currently FDA-recognized standard specifically for low-dead-space needles.
• Labeled Indication: "This device is intended to inject into or aspirate from, the body."

┌────────────────────────────────────────────────────────────────────────┐
│             CONVENTIONAL VS. LOW-DEAD-SPACE (LDS) HUB GEOMETRY         │
├────────────────────────────────────────────────────────────────────────┤
│  CONVENTIONAL FMI NEEDLE HUB:                                          │
│  ┌───────────────┐                                                     │
│  │   Luer void   │ ◄── Residual volume in the hub cavity               │
│  └───┬───────┬───┘     (not a labeled FMI dead-volume claim)           │
│      │Cannula│                                                         │
│                                                                        │
│  TSK STERiJECT QNS NEEDLE HUB (K231734):                               │
│  ┌───────┬───────┐                                                     │
│  │ Solid │ Solid │ ◄── Reduced hub length / filled Luer cavity         │
│  └───┬───┴───┬───┘     Labeled residual dead volume = 0.0028 mL        │
│      │Cannula│                                                         │
└────────────────────────────────────────────────────────────────────────┘

Procurement & Marketing Reality Check: A QNS 510(k) clearance validates mechanical dead volume reduction and biocompatibility. It does not constitute an FDA-approved drug savings claim, nor does it guarantee a specific financial return per vial. Clinics should buy QNS needles for precise micro-droplet fluid delivery and reduced hub retention, but should not make unapproved drug-dose modification claims in clinical protocols.

---

Why ISO 80369-7 Luer Is the Hypodermic Standard (and Why NRFit/ENFit SKUs Do Not Belong on Aesthetic Trays)

Medical connector standards have undergone an international overhaul to prevent lethal misconnections (such as connecting enteral nutrition or epidural lines into intravenous ports). The ISO 80369 series replaces legacy Luer fittings in non-hypodermic medical applications with dedicated, physically non-interchangeable connectors.

Aesthetic practice managers purchasing from broad-line medical distributors must ensure purchasing filters restrict orders to the correct ISO connector family:

1. ISO 80369-7 (Small-Bore Connectors for Intravascular or Hypodermic Applications)

This is the modern 6% Luer taper standard (Luer lock and Luer slip) recognized by FDA (Recognition Number 5-133). Aesthetic hypodermic needles (FMI), standard aesthetic piston syringes (FMF, QNQ), and filler microcannulas should be specified to ISO 80369-7. Labeled low-dead-space needles (QNS) may take an explicit hub-length exception, as K231734 does, while still claiming connection performance against that standard.

2. ISO 80369-6 (Neuraxial and Regional Anesthesia Applications — NRFit)

Classified under product code QEH (Piston Syringe, Neuraxial). NRFit connectors have a 20% smaller diameter than Luer fittings and a distinct collar geometry. NRFit syringes will not connect to standard Luer needles or dermal filler syringes. If purchasing inadvertently orders discounted hospital surplus syringes with QEH / ISO 80369-6 specifications, the syringes cannot mate with any aesthetic needle or cannula.

3. ISO 80369-3 (Enteral Applications — ENFit)

ENFit connectors are designed for feeding tubes. They feature an inverted thread geometry and female-to-male orientation that completely locks out hypodermic Luer connectors.

Procurement Checklist Rule: Every purchase order for aesthetic syringes, needles, luer-to-luer transfer adapters, and microcannulas must explicitly state ISO 80369-7 Luer Lock. For facilities evaluating powered injection hardware, review our guide on aesthetic injector-assist device buying due diligence.

---

What Biomechanical Evidence Shows: 27G Cannulas vs. Needles and Arterial Penetration

A common procurement assumption among injectors is that purchasing smaller-gauge cannulas (e.g., 27G vs. 25G or 22G) maximizes patient safety and eliminates the risk of vascular occlusion. Biomechanical research demonstrates that this assumption is flawed.

In a biomechanical study, Pavicic et al. (Plastic and Reconstructive Surgery, 2019;143(3):504e–512e, PMID 30589824) measured arterial-wall penetration force across 294 procedures on four fresh-frozen human cephalic specimens. Continuously increasing force was applied until intra-arterial penetration of the facial artery or the anterior branch of the superficial temporal artery:

The study's critical finding:

• 27-gauge cannulas vs 27-gauge needles: Force to penetrate was statistically indistinguishable (0.78 N vs 0.70 N, p = 0.558). A 27G blunt cannula is not a mechanical safety upgrade over a 27G needle on this endpoint.
• 22-gauge and 25-gauge cannulas: In every measured size except 27-gauge, cannulas required greater force than correspondingly sized needles. That is still cadaver mechanics (Therapeutic, Level V), not an occlusion incidence rate, and it does not make "any 25G cannula" a substitute for a DFU-named SKU.

Clinical & Procurement Implications

A large survey (Alam et al., JAMA Dermatology 2021, PMID 33377939) of 370 dermatologists reported a lower vascular-occlusion signal with cannulas (1 in 40,882 syringes) than with needles (1 in 6,410 syringes). That observational signal can be true and still not make every 27G cannula a safer purchase than the IFU-named hardware. Neither figure is an incidence rate. Purchasing managers cannot treat a "27G cannula" as a fail-safe substitute for anatomic training and the filler's labeled hardware.

Procurement should stock the cannula gauges explicitly validated in the filler's DFU (such as 25G for Voluma XC). Clinical management of intravascular filler injuries is detailed in our dermal filler complications patient guide.

---

Sterility, Single-Use, Lot, and UDI Rules: Devices vs. Drug Logs

Procurement teams must maintain distinct compliance workflows for consumable medical devices versus prescription drugs:

┌────────────────────────────────────────────────────────────────────────┐
│                   DEVICE UDI VS. DRUG VIAL COMPLIANCE                  │
├────────────────────────────────────────────────────────────────────────┤
│  CLASS II CONSUMABLE DEVICES (Needles, Syringes, Cannulas)             │
│  ├─ Governing Law: 21 CFR 830 / 21 CFR 801 (FDA UDI System)            │
│  ├─ Identification: Device Identifier (DI) + Production Identifier (PI)│
│  ├─ Packaging: Sterile single-use peel pouch with EO / Gamma indicator │
│  ├─ Infection Control: CDC Category IA - Never reuse syringe or needle │
│  └─ Disposal: OSHA 29 CFR 1910.1030 rigid puncture-resistant sharps box│
│                                                                        │
│  PRESCRIPTION DRUGS (Botox, Dysport, Xeomin, Daxxify)                  │
│  ├─ Governing Law: Drug Supply Chain Security Act (DSCSA)              │
│  ├─ Identification: National Drug Code (NDC) + 2D DataMatrix Serial    │
│  ├─ Traceability: Transaction Information (TI), History (TH), Stat (TS)│
│  └─ Clinic Log: Patient ID, Units Drawn, Reconstitution Timestamp      │
└────────────────────────────────────────────────────────────────────────┘

1. CDC Single-Use Mandate (Standard Precautions)

According to the CDC Safe Injection Practices Guidance (Standard Precautions IV.H.2):

• Needles, cannulae, and syringes are sterile, single-use items.
• A syringe or needle must never be used for more than one patient, even if the needle on the syringe is changed.
• A syringe must never be used to access a common medication container or saline bag that will be used for subsequent patients.

Reusing a syringe across multiple patients by simply swapping disposable 30G needles is a Category IA breach of injection safety. CDC documents HBV and HCV outbreaks in U.S. ambulatory settings traced to reused syringes and to reinsertion of used needles into medication containers.

2. FDA Unique Device Identification (UDI)

Under 21 CFR Part 830 and 21 CFR 801.20, Class II needles, syringes, and cannulas generally must bear a Unique Device Identifier (UDI) in both human-readable text and a machine-readable AIDC format unless an FDA exception applies. A complete UDI contains:

• Device Identifier (DI): Mandatory, fixed numeric/alphanumeric code identifying the labeler and specific device model.
• Production Identifier (PI): Variable portion including lot number, serial number, expiration date, and manufacturing date.

Clinics should log device lot numbers in the patient's electronic medical record (EMR) alongside the filler or toxin lot. If a manufacturer or FDA issues a medical device recall (e.g., for hub detachment or sterility barrier compromise), the practice can immediately identify every patient treated with the impacted device lot.

3. OSHA Bloodborne Pathogens & Sharps Disposal

Under OSHA 29 CFR 1910.1030, aesthetic facilities must maintain an Exposure Control Plan. All used needles, cannulas, and pre-filled glass filler syringes must be discarded immediately after use into rigid, puncture-resistant, labeled biohazard sharps containers without recapping or manual shearing. Full regulatory disposal requirements are covered in our guide on med spa medical waste disposal compliance.

For instructions on searching FDA CDRH databases for device clearances, review our protocol on how to verify aesthetic device 510(k) clearance.

---

Frequently Asked Questions

What needle gauge should I buy for dermal filler?

Dermal fillers should be injected using the hardware specified in the product's FDA-approved Directions for Use (DFU). For example, Juvéderm Voluma XC labeling authorizes a 27G ½-inch needle, a 25G 1-inch needle, or a 25G 1½-inch TSK STERiGLIDE microcannula. Pushing a high-G' hyaluronic acid through a much finer needle than the DFU names can increase extrusion force; that is a reason to follow the labeled SKU, not a license to invent a clinic gauge chart.

Is a cannula safer than a needle for filler?

Not automatically. Blunt microcannulas are associated with less bruising in clinical use, and Alam et al. (2021) reported a lower occlusion signal with cannulas than needles among surveyed dermatologists. Cadaveric force testing (Pavicic et al., 2019) showed that 27-gauge cannulas required virtually the same force to penetrate facial arteries as 27-gauge sharp needles (0.78 N vs. 0.70 N). Cannulas still require anatomic knowledge, an appropriate entry needle, and the SKU the filler DFU actually names.

Can I substitute a cheaper 25G cannula for the one named on the filler carton?

While licensed providers have off-label clinical latitude, the filler's DFU explicitly warns that the product is to be "used as supplied" and that modification outside labeling may impact sterility, homogeneity, and performance. Using a generic or off-brand cannula is a labeling and quality decision that sits with the medical director, not a silent equivalent SKU.

Are IV cannula color codes the same as hypodermic needle hub colors?

No. Hypodermic needle hub colors follow ISO 6009:2016 (e.g., 30G is yellow, 27G is grey, 25G is orange). Peripheral IV catheter hubs follow ISO 10555-5 (where 22G is blue and 20G is pink). Never use hospital IV catheter color charts to order aesthetic hypodermic consumables.

Do low-dead-space needles save Botox units?

Low-dead-space needles (cleared under FDA product code QNS, such as TSK K231734) are labeled with a hub residual as low as 0.0028 mL. That mechanical claim is not an FDA-approved Botox-unit savings statement and does not change labeled reconstitution or dosing.

Is an aesthetic microcannula FDA-cleared?

Aesthetic microcannulas marketed in the United States are typically Class II devices cleared via the FDA 510(k) pathway (primarily under product code FMI, 21 CFR 880.5570 — for example K223327, indicated for intradermal injection in adults greater than 21 years old, and K200017) or named as accessories in a dermal filler's Premarket Approval labeling (such as the TSK STERiGLIDE 25G 1½-inch cannula in the Voluma XC DFU after P110033/S042). A category 510(k) does not make the SKU interchangeable with a PMA-named accessory.

---

Sources

• 21 CFR 880.5570 — Hypodermic single lumen needle, Class II
• FDA Product Classification Database — Product Code FMI (Needle, Hypodermic, Single Lumen)
• FDA Product Classification Database — Product Code QNS (Low Dead Space Needle, Single Lumen, Hypodermic)
• FDA Product Classification Database — Product Code FMF (Piston Syringe)
• FDA Recognized Consensus Standard ISO 7864:2016 — Sterile hypodermic needles for single use (Recognition 6-379)
• FDA Recognized Consensus Standard ISO 6009:2016 — Hypodermic needles for single use — Colour coding for identification (Recognition 6-381)
• FDA PMA P110033/S042 — JUVÉDERM VOLUMA XC Cannula Labeling Update Approval Order
• FDA PMA P110033/S070 — JUVÉDERM VOLUMA XC temple indication approval order
• FDA PMA P110033/S070 Directions for Use PDF — JUVÉDERM VOLUMA XC
• FDA 510(k) K231734 Summary — TSK STERiJECT Low Dead Space Needle (Product Code QNS)
• FDA 510(k) K223327 Summary — Sterile Aesthetic Cannula and Hypodermic Needle (Product Code FMI)
• DailyMed — BOTOX Cosmetic (onabotulinumtoxinA) Prescribing Information (Oct 2024)
• CDC Safe Injection Practices Clinical Guidance — Standard Precautions for Infection Control
• Pavicic T et al. Arterial Wall Penetration Forces in Needles versus Cannulas. Plast Reconstr Surg. 2019;143(3):504e–512e. PMID 30589824
• Alam M et al. Rates of Vascular Occlusion Associated With Using Needles vs Cannulas for Filler Injection. JAMA Dermatol. 2021;157(2):174–180. PMID 33377939
• OSHA 29 CFR 1910.1030 — Bloodborne pathogens